Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis
E Balsells, L Guillot, H Nair, MH Kyaw - PloS one, 2017 - journals.plos.org
Background Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13)
has reduced invasive pneumococcal disease (IPD) due to vaccine serotypes significantly …
has reduced invasive pneumococcal disease (IPD) due to vaccine serotypes significantly …
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious …
JS Bradley, CL Byington, SS Shah… - Clinical infectious …, 2011 - academic.oup.com
Evidenced-based guidelines for management of infants and children with community-
acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and …
acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and …
Serotype replacement in disease after pneumococcal vaccination
DM Weinberger, R Malley, M Lipsitch - The Lancet, 2011 - thelancet.com
Vaccination with heptavalent pneumococcal conjugate vaccine (PCV7) has significantly
reduced the burden of pneumococcal disease and has had an important public health …
reduced the burden of pneumococcal disease and has had an important public health …
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
T Pilishvili, C Lexau, MM Farley, J Hadler… - The Journal of …, 2010 - academic.oup.com
Background Changes in invasive pneumococcal disease (IPD) incidence were evaluated
after 7 years of 7-valent pneumococcal conjugate vaccine (PCV7) use in US children …
after 7 years of 7-valent pneumococcal conjugate vaccine (PCV7) use in US children …
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites
DR Feikin, EW Kagucia, JD Loo, R Link-Gelles… - PLoS …, 2013 - journals.plos.org
Background Vaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined
substantially following introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into …
substantially following introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into …
[HTML][HTML] Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal …
JP Nuorti, CG Whitney - 2010 - cdc.gov
SUMMARY On February 24, 2010, a 13-valent pneumococcal polysaccharide-protein
conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., marketed by Pfizer …
conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals Inc., marketed by Pfizer …
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 …
LA Hicks, LH Harrison, B Flannery… - The Journal of …, 2007 - academic.oup.com
Background. Widespread use of pneumococcal conjugate vaccine (PCV7) resulted in
decreases in invasive disease among children and elderly persons. The benefits may be …
decreases in invasive disease among children and elderly persons. The benefits may be …
Emergence of parapneumonic empyema in the USA
Background Although recent reports suggest that the incidence of parapneumonic empyema
has increased in several regions of the USA, national trends in disease burden are …
has increased in several regions of the USA, national trends in disease burden are …
Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005
MR Moore, RE Gertz, Jr, RL Woodbury… - The Journal of …, 2008 - academic.oup.com
Background Serotype 19A invasive pneumococcal disease (IPD) increased annually in the
United States after the introduction of the 7-valent conjugate vaccine (PCV7). To understand …
United States after the introduction of the 7-valent conjugate vaccine (PCV7). To understand …
New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine
JR Casey, DG Adlowitz… - The Pediatric infectious …, 2010 - journals.lww.com
Objective: To describe NP and AOM otopathogens during the time frame 2007 to 2009, 6 to
8 years after the introduction of 7-valent pneumococcal conjugate (PCV7) in the United …
8 years after the introduction of 7-valent pneumococcal conjugate (PCV7) in the United …